WHO ICTRP trial
HAKUOH Study
JPRN-jRCTs051190039 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs051190039 |
|---|---|
| Public title | HAKUOH Study |
| Scientific title | A nonrandomized, non-double blinded prospective cohort study to evaluate the preventive efficacy of quadrivalent HPV6/11/16/18 vaccine (Gardasil) for the persistent infection of HPV16 genotype or HPV18 genotype in Japanese women aged 27-45 years. - HAKUOH Study |
| Primary sponsor | Yoshida Yoshio |
| Secondary sponsors | Shinagawa Akiko |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 0 |
| Conditions | Uterine cervical cancer HPV infection;HPV infection |
| Interventions | arm A:vaccine group 3 times(0 month, 2 month, 6 month) arm B:non-vaccine group |
| Registration date | Aug 21, 2019 |
| Target size | 2100 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: